Background
Clostridium difficile (
C. difficile
) infection can have serious implications on patient outcomes, especially post ileostomy reversal. The symptoms can range from asymptomatic/mild to severe, with significant morbidity or mortality. Thus far, no study has been published to determine the role and impact of preoperative
C. difficile
testing prior to ileostomy reversal. The aim of this audit was to identify risk factors for the development of post-ileostomy reversal
C. difficile
infection and provide further improvements and direction for future research.
Methods
All patients undergoing ileostomy reversal at the General Surgery Department at Sir Charles Gairdner Hospital, a tertiary centre in Perth, Western Australia, were retrospectively identified between January 2019 and June 2021. Demographics and key data points, such as specific types of antibiotic usage, were extracted from patient notes and analysed using IBM SPSS Statistics for Windows, version 27 (released 2020; IBM Corp., Armonk, New York, United States).
Results
Sixty-nine patients were identified in the audit period, with 8.70% of patients testing positive for
C. difficile
infection post ileostomy reversal. At the index ileostomy formation operation, postoperative use of quinolone antibiotics was statistically associated with an increased risk of developing
C. difficile
on ileostomy reversal (odds ratio (OR) = 15.25, confidence interval (CI) 95%, p = 0.035). Intraoperative nitroimidazole use was statistically associated with a reduced risk of
C. difficile
infection on ileostomy reversal (OR = 0.16, CI 95%, p = 0.045). Patients who had diverticulitis as their underlying disease pathology were 10 times more likely to develop
C. difficile
infection post ileostomy reversal, although this finding was not statistically significant in our study.
Conclusion
Several risk factors were identified, such as the use of quinolone antibiotics or having underlying diverticulitis as causes for ileostomy formation. The results from this audit provides further direction in designing further research studies into the role and impact of
C. difficile
testing and treatment in the perioperative period around ileostomy reversal.